A multiple-comparisons test among the serum Wnt5a concentrations in relation to each CKD stage showed that there were significant differences between stages 1 and 3, stages 1 and 4, stages 2 and 3, and stages 3 and 4. This evidence concerns the gene WNT5A and chronic kidney disease.